Dolby Laboratories (DLB) Liabilities and Shareholders Equity (2009 - 2026)

Dolby Laboratories has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $3.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 0.63% year-over-year to $3.2 billion; the trailing twelve-month figure through Mar 2026 stood at $12.9 billion (up 3.16% YoY), and the FY2025 full-year result was $3.2 billion, up 3.79% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $3.2 billion, up from $3.2 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $3.2 billion in Q1 2026, with the low at $2.7 billion in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $3.0 billion across 5 years, with a median of $3.0 billion in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity decreased 13.4% — and 2023, when it climbed 10.79%.
• Dolby Laboratories' Liabilities and Shareholders Equity stood at $2.7 billion in 2022, then grew by 6.8% to $2.9 billion in 2023, then advanced by 7.6% to $3.2 billion in 2024, then increased by 1.06% to $3.2 billion in 2025, then climbed by 1.8% to $3.2 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $3.2 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.2 billion (Q3 2025), per Business Quant data.